anastrozole has been researched along with Atrophy in 4 studies
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Anastrozole is a selective aromatase inhibitor and is used for the hormonal treatment of postmenopausal breast cancer." | 7.74 | Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer. ( Akgul, B; Camci, C; Kalender, ME; Karakok, M; Sevinc, A; Turk, HM, 2007) |
| "Anastrozole is a selective aromatase inhibitor and is used for the hormonal treatment of postmenopausal breast cancer." | 3.74 | Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer. ( Akgul, B; Camci, C; Kalender, ME; Karakok, M; Sevinc, A; Turk, HM, 2007) |
| "Breast cancer is one of the most common malignancies in women." | 1.43 | Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study. ( Arpino, G; De Placido, G; De Placido, S; De Rosa, P; Locci, M; Nazzaro, G; Pagano, T; Schettini, F; Vallone, R, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pagano, T | 1 |
| De Rosa, P | 1 |
| Vallone, R | 1 |
| Schettini, F | 1 |
| Arpino, G | 1 |
| De Placido, S | 1 |
| Nazzaro, G | 1 |
| Locci, M | 1 |
| De Placido, G | 1 |
| Kalender, ME | 1 |
| Sevinc, A | 1 |
| Camci, C | 1 |
| Turk, HM | 1 |
| Karakok, M | 1 |
| Akgul, B | 1 |
| Koloszar, S | 1 |
| Pal, Z | 1 |
| Kereszturi, A | 1 |
| Vajda, G | 1 |
| Pal, A | 1 |
| Daru, J | 1 |
| Wengström, Y | 1 |
1 review available for anastrozole and Atrophy
| Article | Year |
|---|---|
Effectively nursing patients receiving aromatase inhibitor therapy.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromat | 2008 |
3 other studies available for anastrozole and Atrophy
| Article | Year |
|---|---|
Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study.
Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Breast Neoplasms; Female; Huma | 2016 |
Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Atrophy; Breast Neoplasms; Fatal Outcome; Female | 2007 |
Effects of aromatase inhibitor on menopausal hyperplasia in a case of obesity.
Topics: Administration, Oral; Aged; Anastrozole; Aromatase Inhibitors; Atrophy; Endometrial Hyperplasia; End | 2012 |